Lv2
136 积分 2026-02-10 加入
Survodutide Once Weekly for the Treatment of Adults with Obesity
11天前
已完结
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines
13天前
已完结
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial
25天前
已关闭
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial
25天前
已完结
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes
27天前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已完结
The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study
2个月前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2个月前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
2个月前
已关闭
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
2个月前
已完结
皖公网安备34019202002308
